U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07581197) titled 'Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes' on May 01.
Brief Summary: This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA or blood types, immunosuppression to prevent rejection will be required in this first in human study.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Diabete Mellitus
Diabete Type 1
Intervention:
BIOLOGICAL...